Loading…
MIRA Pharmaceuticals, Inc. is projected to rise to $1.52 by 2027, a +32% move from its current price of $1.16. MIRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.11 | $1.15 | $1.21 | -0.01% |
| May 30 | $1.09 | $1.15 | $1.23 | -0.02% |
| May 31 | $1.07 | $1.15 | $1.24 | -0.03% |
| Jun 1 | $1.06 | $1.15 | $1.26 | -0.04% |
| Jun 2 | $1.05 | $1.15 | $1.27 | -0.05% |
| Jun 3 | $1.04 | $1.15 | $1.28 | -0.06% |
| Jun 4 | $1.03 | $1.15 | $1.29 | -0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.03 | $1.15 | $1.29 | -0.07% |
| Week 2 | $0.9832 | $1.15 | $1.35 | -0.13% |
| Week 3 | $0.9479 | $1.15 | $1.40 | -0.20% |
| Week 4 | $0.919 | $1.15 | $1.44 | -0.26% |
| Week 5 | $0.8942 | $1.15 | $1.48 | -0.33% |
| Week 6 | $0.8724 | $1.15 | $1.52 | -0.40% |
| Week 7 | $0.8527 | $1.15 | $1.55 | -0.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MIRA Pharmaceuticals, Inc. is a healthcare company that operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. It holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial.
The company also offers MIRA-55, an oral pharmaceutical marijuana, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
It was formerly known as MIRA1a Therapeutics, Inc.
MIRA Pharmaceuticals, Inc. (MIRA) is trading at $1.16 per share in the healthcare sector, and its market position is reflected by a market cap of $48.54M with a rank of 4557. The current price and market position set the stage for a longer-term price outlook that features upside potential across the forecast horizon.
The 2026–2050 forecast shows an average price path rising from $1.16 in 2026 to $5.06 by 2050, with a max price reaching $11.34 and a min around $0.92 early in the period. Cumulative ROIs rise from 0% in 2026 to as high as 338.4% by 2050, with bullish sentiment intensifying in later years.
A major floor 23.7% below — a decisive break under it would weaken the trend.
The nearest floor, 17.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 26.4% above — clearing it would confirm fresh momentum.
Key MIRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MIRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.02 | Buy | $1.04 | Buy |
| MA 10 | $0.9912 | Buy | $1.01 | Buy |
| MA 20 | $1.00 | Buy | $1.01 | Buy |
| MA 50 | $1.03 | Buy | $1.06 | Buy |
| MA 100 | $1.17 | Sell | $1.14 | Buy |
| MA 200 | $1.30 | Sell | $1.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.25 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 325.02 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 17.02 | Buy |
| Bollinger %B (20,2) | 1.37 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.29 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 76.30 | Sell |
| Momentum (10) | 0.13 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 1.04 | Buy |
| ADX (14) | 14.81 | Neutral |
| ATR (14) | 0.03 | Info |
Technical sentiment is BULLISH. The RSI14 is 70, and the near-term trend is supported by a SMA50 of $1.03 and a SMA200 of $1.30. Near-term support is $0.95 and resistance is $1.15, suggesting a defined trading band around the current level.
The 30-day price range extends from $0.8717 to $1.53, indicating a degree of volatility within a relatively tight window over the past month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.92 | $1.16 | $1.76 | 0% | Neutral | |
| $1.14 | $1.52 | $2.18 | +32% | Bullish | |
| $1.13 | $1.57 | $2.37 | +36% | Bullish | |
| $1.07 | $1.55 | $2.44 | +34% | Bullish | |
| $1.05 | $1.57 | $2.55 | +36% | Bullish | |
| $0.909 | $1.41 | $2.36 | +22% | Bullish | |
| $1.06 | $1.69 | $2.90 | +46% | Bullish | |
| $1.39 | $2.28 | $4.02 | +98% | Bullish | |
| $1.32 | $2.23 | $4.02 | +93% | Bullish | |
| $1.35 | $2.35 | $4.31 | +103% | Bullish | |
| $1.59 | $3.15 | $6.27 | +173% | Bullish | |
| $2.28 | $5.06 | $11.34 | +338% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.92 | $1.16 | $1.37 | +0.00% |
| June 2026 | $0.983 | $1.17 | $1.43 | +1.19% |
| July 2026 | $0.9503 | $1.15 | $1.43 | -2.02% |
| August 2026 | $0.9946 | $1.21 | $1.54 | +5.76% |
| September 2026 | $1.05 | $1.29 | $1.66 | +6.18% |
| October 2026 | $1.02 | $1.27 | $1.65 | -1.45% |
| November 2026 | $1.01 | $1.26 | $1.66 | -0.69% |
| December 2026 | $1.06 | $1.33 | $1.76 | +5.48% |
Click any year to see its month-by-month MIRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MIRA price prediction for 2026 points to an average of $1.16 (low $0.92, high $1.76) — a potential gain of 0% on today's $1.16. Price action looks broadly range-bound.
In 2027, MIRA is projected to trade between $1.14 and $2.18, averaging $1.52 — a potential gain of +32% from today's $1.16. That is up +32% on the projected 2026 average. Buyers look set to stay in control over this stretch.
MIRA Pharmaceuticals, Inc.'s 2028 outlook centres on $1.57, within a $1.13 to $2.37 range. That is up +3% on the projected 2027 average. That marks a +36% change versus current levels. Momentum favours further upside here.
By 2029, MIRA could reach as high as $2.44, with a base case around $1.55 and support toward $1.07 — roughly +34% from $1.16. Buyers look set to stay in control over this stretch.
Expect MIRA to range from $1.05 to $2.55 through 2030. The $1.57 average target implies a +36% move from current prices. That is up +1% on the projected 2029 average. Momentum favours further upside here.
The MIRA price prediction for 2031 points to an average of $1.41 (low $0.909, high $2.36) — a potential gain of +22% on today's $1.16. Buyers look set to stay in control over this stretch.
In 2032, MIRA is projected to trade between $1.06 and $2.90, averaging $1.69 — a potential gain of +46% from today's $1.16. That is up +20% on the projected 2031 average. Momentum favours further upside here.
MIRA Pharmaceuticals, Inc.'s 2033 outlook centres on $2.28, within a $1.39 to $4.02 range. That is up +35% on the projected 2032 average. That marks a +98% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MIRA could reach as high as $4.02, with a base case around $2.23 and support toward $1.32 — roughly +93% from $1.16. Momentum favours further upside here.
Expect MIRA to range from $1.35 to $4.31 through 2035. The $2.35 average target implies a +103% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MIRA price prediction for 2040 points to an average of $3.15 (low $1.59, high $6.27) — a potential gain of +173% on today's $1.16. Momentum favours further upside here.
In 2050, MIRA is projected to trade between $2.28 and $11.34, averaging $5.06 — a potential gain of +338% from today's $1.16. That is up +61% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MIRA today (≈ 865.800866 MIRA) could be worth
$4,383.54
+$3,383.54 (+338%) by 2050 · US Dollar
Based on the average projected MIRA price of $5.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MIRAwould be worth at today's price.
$1,000 invested in MIRA on May 27, 2025 (≈ 793.6508 MIRA) would be worth
$916.67
-$83.33 (-8.3%) today · 0.92× · US Dollar
Based on a MIRA entry price of $1.26 vs. today's $1.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.968 | $1,193.18 | +19.3% |
| 1 month ago | $1.02 | $1,132.35 | +13.2% |
| 3 months ago | $1.33 | $868.42 | -13.2% |
| 6 months ago | $1.48 | $780.41 | -22.0% |
| 1 year ago | $1.26 | $916.67 | -8.3% |
| All time (2.8y) ago | $7.42 | $155.66 | -84.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MIRA forecast.
Our base-case forecast reaches $2.30 around 2035.
Implied market cap at $2.30: $96.65M
The multi-year forecast shows a bullish trajectory with rising average prices across the horizon. The 2026 average is $1.16, stepping up through 2027 at $1.52, 2028 at $1.57, 2029 at $1.55, and 2030 at $1.57, with long-run momentum building toward $5.06 by 2050. Max prices rise to $2.55 in 2030, $2.90 in 2032, and $11.34 by 2050, while min prices trend higher across the period (e.g., $1.05 in 2030 and $2.28 in 2050).
ROI figures accompany each point, ranging from 0% in 2026 to 36% in 2030, 172.5% in 2040, and 338.4% in 2050, reflecting meaningful but uncertain upside. The forecast is described as bullish in many years, but volatility is substantial, with an annualized volatility of 80% cited as a risk factor. These numbers are estimates, not guarantees, and should be considered in the context of sector risks and execution uncertainties.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $1.57, with a min of $1.05 and a max of $2.55, and an estimated ROI of 36%.
The longer-term forecast is bullish, with the average price rising to $5.06 by 2050 and ROI up to 338.4%. In 2027 the average is $1.52 and sentiment is bullish, though these are estimates, not guarantees.
Yes. The forecast shows a max of $2.55 in 2030 and $2.90 in 2032, with earlier years like 2029 having a max of $2.44.
Current price is $1.16 and market cap is $48.54M.
RSI14 is 70 with sentiment BULLISH. The SMA50 is $1.03 and the SMA200 is $1.30. Support is at $0.95 and resistance at $1.15. The 30-day range is $0.8717 to $1.53.
MIRA Pharmaceuticals, Inc. Community Discussion
0Share your MIRA Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.